Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl) in the framework of the Council Decision on new psychoactive substances
Introduction
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 15 November 2017, the Council decided that furanylfentanyl should be subject to control measures across the Member States.
Download as PDF
Table of contents
- Foreword
- EMCDDA actions on monitoring and responding to new drugs
- EMCDDA–Europol Joint Report on furanylfentanyl: a summary
- Risk Assessment Report of a new psychoactive substance: furanylfentanyl
- Annex 1: Technical report on furanylfentanyl
- Council Decision on subjecting furanylfentanyl to control measures
- Participants of the risk assessment meeting
Pages:
49
Price:
Free
ISBN:
978-92-9497-244-6
ISSN:
1725-4493
Pub. DOI:
10.2810/22200
Catalog Number:
TD-AK-17-002-EN-C
Main subject